Metabolite Profiling of Ortho-, Meta- and Para-Fluorofentanyl by Hepatocytes and High-Resolution Mass Spectrometry.


Journal

Journal of analytical toxicology
ISSN: 1945-2403
Titre abrégé: J Anal Toxicol
Pays: England
ID NLM: 7705085

Informations de publication

Date de publication:
07 Mar 2020
Historique:
received: 26 03 2019
revised: 12 07 2019
accepted: 28 07 2019
pubmed: 4 12 2019
medline: 30 4 2020
entrez: 3 12 2019
Statut: ppublish

Résumé

New psychoactive substances are emerging on the illegal drug market. Synthetic opioids including fentanyl analogues are of special concern due to their high potency. This indicates the possibility of low drug concentrations in vivo and calls for sensitive analytical methods and identification of the most appropriate analytical targets. In this study the in vitro metabolism of ortho-, meta- and para-fluorofentanyl, three fluorinated derivatives of fentanyl, has been investigated using human hepatocytes and compared to the results from an authentic human urine sample. Based on knowledge on the metabolism of similar fentanyl analogues N-dealkylation and hydroxylation was hypothesized to be the most central pathways. The three fluorofentanyl isomers were incubated with pooled human hepatocytes at 1, 3 and 5 h. Liquid chromatography quadrupole time of flight mass spectrometry operating in data-dependent mode was used to analyse the hepatocyte samples, as well as the hydrolysed and non-hydrolysed authentic urine sample. Data were analysed by a targeted approach with a database of potential metabolites. The major metabolite formed in vitro was the N-dealkylation product norfluorofentanyl. In addition various hydroxylated metabolites, a N-oxide, dihydrodiol metabolites and a hydroxymethoxy metabolite were found. In total, 14 different metabolites were identified for each fluorofentanyl isomer. In the authentic urine sample, three metabolites were detected in addition to the ortho-fluorofentanyl parent compound, with hydroxymethoxy metabolite having the highest abundance followed by norfluorofentanyl and a metabolite hydroxylated on the ethylphenyl ring. This in vitro study showed that the metabolic pattern for ortho-, meta-, and para-fluorofentanyl was close to those previously reported for other fentanyl analogues. We suggest that the hydroxymethoxy metabolite and the metabolite hydroxylated on the ethylphenyl ring should be the metabolites primarily investigated in further studies to determine the most appropriate marker for intake of fluorofentanyl derivatives in urine drug screening for human subjects.

Identifiants

pubmed: 31788682
pii: 5627731
doi: 10.1093/jat/bkz081
pmc: PMC7238673
doi:

Substances chimiques

Analgesics, Opioid 0
Designer Drugs 0
Illicit Drugs 0
Fentanyl UF599785JZ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-148

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Références

Drug Test Anal. 2017 Jul;9(7):1085-1092
pubmed: 27736030
AAPS J. 2016 Nov;18(6):1489-1499
pubmed: 27495118
J Biol Chem. 2011 Jul 22;286(29):25419-25
pubmed: 21632546
J Pharmacol Exp Ther. 2000 Sep;294(3):1024-33
pubmed: 10945855
Arch Toxicol. 2019 Jan;93(1):95-106
pubmed: 30361799
J Anal Toxicol. 2017 Oct 1;41(8):708-709
pubmed: 28985336
AAPS J. 2017 Jul;19(4):1102-1122
pubmed: 28382544
Forensic Sci Int. 2016 Sep;266:170-177
pubmed: 27289433
J Anal Toxicol. 2017 Jun 1;41(5):367-375
pubmed: 28369517
Ther Drug Monit. 2019 Aug;41(4):519-527
pubmed: 30807539
Anesth Analg. 1996 Jan;82(1):167-72
pubmed: 8712396
Drug Metab Dispos. 1997 Sep;25(9):1072-80
pubmed: 9311623
Chem Res Toxicol. 1992 Sep-Oct;5(5):639-46
pubmed: 1446003

Auteurs

Per Ole M Gundersen (POM)

Department of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway.
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Anna Åstrand (A)

Division of Drug Research, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.

Henrik Gréen (H)

Division of Drug Research, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden.

Martin Josefsson (M)

Department of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden.
National Forensic Centre, Drug Unit, Linköping, Sweden.

Olav Spigset (O)

Department of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway.
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Svante Vikingsson (S)

Division of Drug Research, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH